BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1464 related articles for article (PubMed ID: 30822098)

  • 1. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
    Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
    Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
    [No Abstract]   [Full Text] [Related]  

  • 2. Underutilization of Pulmonary Function Testing in Veterans Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation: Who are We Missing?
    Bade BC; DeRycke EC; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Cain HC; Brandt C; Bastian LA; Akgün KM
    COPD; 2020 Feb; 17(1):15-21. PubMed ID: 31948267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
    Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.
    Keshishian A; Xie L; Dembek C; Yuce H
    Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of guideline-based therapy for chronic obstructive pulmonary disease: Differences between men and women veterans.
    Rinne ST; Elwy AR; Liu CF; Wiener RS; Thayer L; Gerity A; Bastian LA
    Chron Respir Dis; 2017 Nov; 14(4):385-391. PubMed ID: 28618875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations.
    Spece LJ; Epler EM; Donovan LM; Griffith MF; Collins MP; Feemster LC; Au DH
    Ann Am Thorac Soc; 2018 Sep; 15(9):1033-1038. PubMed ID: 30079748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease.
    Singh U; Wangia-Anderson V; Bernstein JA
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):279-285.e6. PubMed ID: 30053594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Care Delivered to Veterans with COPD Exacerbation and the Association with 30-Day Readmission and Death.
    Spece LJ; Donovan LM; Griffith MF; Collins MP; Feemster LC; Au DH
    COPD; 2018 Oct; 15(5):489-495. PubMed ID: 30822247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Related Differences in the Rate, Timing, and Diagnosis of 30-Day Readmissions in Hospitalized Adults With Asthma Exacerbation.
    Hasegawa K; Gibo K; Tsugawa Y; Shimada YJ; Camargo CA
    Chest; 2016 Apr; 149(4):1021-9. PubMed ID: 26836926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission.
    Tran M; Xiang P; Rascati KL; Stock EM; Godley PJ; Coleman A; Bogart MR; Stanford RH
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1186-93. PubMed ID: 27668567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.
    Singh G; Zhang W; Kuo YF; Sharma G
    Chest; 2016 Apr; 149(4):905-15. PubMed ID: 26204260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.
    Bishwakarma R; Zhang W; Kuo YF; Sharma G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():477-486. PubMed ID: 28203071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.
    Johannesdottir SA; Christiansen CF; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Fryzek JP
    J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
    Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
    Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions.
    Loh CH; Peters SP; Lovings TM; Ohar JA
    Ann Am Thorac Soc; 2017 Aug; 14(8):1305-1311. PubMed ID: 28406710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.
    Cydulka RK; Rowe BH; Clark S; Emerman CL; Rimm AR; Camargo CA
    Acad Emerg Med; 2005 Dec; 12(12):1173-9. PubMed ID: 16282511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD.
    Adamson SL; Burns J; Camp PG; Sin DD; van Eeden SF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():61-71. PubMed ID: 26792986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Goto T; Hirayama A; Faridi MK; Camargo CA; Hasegawa K
    Ann Am Thorac Soc; 2018 Feb; 15(2):184-191. PubMed ID: 29053337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.